1. Home
  2. SGHT vs TG Comparison

SGHT vs TG Comparison

Compare SGHT & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$7.13

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Logo Tredegar Corporation

TG

Tredegar Corporation

HOLD

Current Price

$7.79

Market Cap

262.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
SGHT
TG
Founded
2011
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
309.6M
262.4M
IPO Year
2021
1994

Fundamental Metrics

Financial Performance
Metric
SGHT
TG
Price
$7.13
$7.79
Analyst Decision
Buy
Analyst Count
7
0
Target Price
$9.08
N/A
AVG Volume (30 Days)
148.4K
112.5K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
28.16
151.06
EPS
N/A
0.17
Revenue
$77,363,000.00
$800,821,000.00
Revenue This Year
$11.67
N/A
Revenue Next Year
$10.39
N/A
P/E Ratio
N/A
$45.71
Revenue Growth
N/A
8.29
52 Week Low
$3.19
$6.25
52 Week High
$9.24
$10.53

Technical Indicators

Market Signals
Indicator
SGHT
TG
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
SGHT
TG

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

About TG Tredegar Corporation

Tredegar Corp is engaged in the manufacture of aluminum extrusions and polyethylene and polypropylene plastic films. It produces surface protection films, packaging films and films for other markets. The company continues to have two reportable segments: Aluminum Extrusions and High Performance Films. The majority of the revenue is derived form the Aluminum Extrusions segment which produces high-quality, soft and medium strength alloyed aluminum extrusions, custom fabricated and finished, for the building and construction, automotive and transportation, consumer durables goods, machinery and equipment, electrical and renewable energy, and distribution markets.

Share on Social Networks: